HD201: Analytical biocomparability and clinical trial progression of trastuzumab.

Hii, J; Pivot, X; Park, LS; Kim, M; Feyaerts, P; Chan, KW; Lee, JH; Ang, F

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):